Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01510327
Show Display Options
Download search resultsDownload the search results for:
NCT01510327 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting
Has Results
PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Everolimus-Eluting Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine

Indicates status has not been verified in more than two years